1988
DOI: 10.1128/iai.56.11.2818-2821.1988
|View full text |Cite
|
Sign up to set email alerts
|

Naturally occurring antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal antibody-based competitive enzyme-linked immunosorbent assay

Abstract: The antibody response to an epitope on gamete antigens of Plasmodium fakciparum in persons naturally exposed to malaria has been investigated by competitive enzyme-linked immunosorbent assay. The assay detects antibodies to an epitope on the 48/45-kilodalton (kDa) gamete surface antigen by competition with horseradish peroxidase-labeled monoclonal antibody 11C5-B10. Five sera previously shown to immunoprecipitate the 230and 48/45-kDa antigens significantly inhibited 1IC5-B10 binding to an average of 24.2% of c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
1

Year Published

1990
1990
2021
2021

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(8 citation statements)
references
References 12 publications
0
7
1
Order By: Relevance
“…No reaction was found in our two-site ELISAs with MoAb 3G12. Enhancement of binding of HRPO-labelled MoAbs in the presence of sera to the captured antigen was never seen in these competition ELISAs (data not shown) in contrast to findings by Targett et al (1990b) or Graves et al (1988bGraves et al ( , 1991Graves et al ( and 1992.…”
Section: Discussioncontrasting
confidence: 63%
See 2 more Smart Citations
“…No reaction was found in our two-site ELISAs with MoAb 3G12. Enhancement of binding of HRPO-labelled MoAbs in the presence of sera to the captured antigen was never seen in these competition ELISAs (data not shown) in contrast to findings by Targett et al (1990b) or Graves et al (1988bGraves et al ( , 1991Graves et al ( and 1992.…”
Section: Discussioncontrasting
confidence: 63%
“…In another study, MoAb IIC5.B10 was used to compete with a panel of Papua New Guinea sera. The results of the competition ELISA did not correlate with transmission-blocking activity observed in these field sera (Graves et al 1988a and1988b). We have previously described a correlation between suppression of infectivity of in vitro cultured gametocytes to mosquitoes in a bioassay and reactivity in an anti-Pfs48/45 two-site competition ELISA by immune sera (Roeffen et al 1995a).…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…Foundational and novel studies have identified various factors that correlate with an increase in gametocytogenesis. These include, but are not limited to, host immunity Graves et al, 1988;Motard et al, 1995;Buckling et al, 1999), regulation of the key parasite genes GDV1 and AP2-G (Day et al, 1993;Eksi et al, 2012;Brancucci et al, 2014;Coleman et al, 2014;Kafsack et al, 2014;Filarsky et al, 2018;Josling et al, 2020), host lipid and biomolecule biosynthesis and metabolism (Gulati et al, 2015;Brancucci et al, 2017;Tanaka et al, 2019;Tewari et al, 2020), fluctuations in host hormone production (Trager and Gill, 1992;Lingnau et al, 1993), and chemotherapy (Puta and Manyando, 1997;Robert et al, 2000;Tjitra et al, 2002;Hamel et al, 2005;Elbasit et al, 2006;Schneider et al, 2006). Each of these triggers may be altered in the context of a co-morbidity such as HIV-1.…”
Section: Background Overview Of Malaria Parasite Transmissionmentioning
confidence: 99%
“…In the middle is a representation of the life cycle of Plasmodium falciparum (adapted from NIAID/NIH, 2016, https://www.niaid.nih.gov/diseases-conditions/malaria-parasite) representing the exoerythrocytic (liver) cycle, erythrocytic cycle (bloodstream), and sexual stage (gametocyte) development in the host, and the sporogonic cycle in the mosquito. Patnaik et al, 2005;9 Abu-Raddad et al, 2006;10 Laufer et al, 2006;11 Onyenekwe et al, 2007;12 Van Geertruyden et al, 2008;13 Stiffler et al, 2020;14 Trott et al, 2011;15 Koehler et al, 2009;16 Okonkwo et al, 2016;17 Mbale et al, 2016;18 Graves et al, 1988;19 Nassir et al, 2005;20 Lingnau et al, 1993;21 Bousema et al, 2011;22 Belperio and Rhew, 2004;23 Eksi et al, 2012;24 Brancucci et al, 2014;25 Josling et al, 2020;26 Coleman et al, 2014;27 Kafsack et al, 2014;28 Filarsky et al, 2018;29 Hobbs et al, 2013;30 Azevedo et al, 2019;31 Buckling et al, 1999;32 Elbasit et al, 2006;33 Ittiravivongs et al, 1984;34 Josling et al, 2018;35 Sandison et al, 2011;36 Puta and Manyando, 1997;37 Schneider et al, 2006;38 Barnes et al, 2008;39 Bouyou Akotet et al, 2018;40 Sowunmi et al, 2008;41 Quintero et al, 2011;42 Nacher et al, 2002;43 Tay et al, 2015;44 Sanyaolu et al, 2013;45 Hogh et al, 1998;…”
Section: Immune Statusmentioning
confidence: 99%